Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
This completed clinical trial update reports location-molecular integrated outcomes from 450 cerebellar glioma microsurgical cases.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM [Phase 2]
BIO-SHORT is a Phase 2 trial evaluating biologically guided short-course hypofractionated radiotherapy for poorly prognostic glioblastoma. T…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors [Phase 1]
Phase 1 clinical trial evaluating hyperpolarized carbon-13 pyruvate imaging to aid the diagnosis of glioma in patients with brain tumors; cu…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma [EARLY_Phase 1]
Early-phase clinical trial investigating hyperpolarized carbon-13 alpha-ketoglutarate imaging in IDH-mutant glioma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas [NA]
A ClinicalTrials.gov study is investigating brain stimulation combined with behavioral therapy to increase the extent of surgical resection …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Platelets Activation in Brain Neoplasms [NA]
A clinical trial investigating platelets activation in brain neoplasms, including glioma, is currently recruiting. The sponsor is Fondation …
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy [Phase 4]
A Phase 4 clinical trial sponsored by Mayo Clinic comparing telehealth and in-person assessments in glioma patients undergoing oral chemothe…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]
Phase 2 ascending-dose study of RVP-001, a manganese-based MRI contrast agent, completed to assess safety and preliminary efficacy in CNS le…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies
Mayo Clinic is advancing desorption electrospray ionization mass spectrometry (DESI-MS) for intraoperative molecular diagnosis of brain canc…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma [NA]
A recruiting clinical trial at the University of Rochester is exploring telehealth visits to discuss advanced directives for patients newly …
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors [Phase 1]
Phase 1 trial evaluating locoregional HER2-targeted CAR T-cell therapy for pediatric recurrent or refractory central nervous system tumors a…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors [Phase 1]
Phase 1 trial evaluating locoregional EGFR806-specific CAR T cells for EGFR-positive pediatric CNS tumors. The study status is completed.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: NeuroPathways Intervention for Brain Tumor Patients [NA]
A clinical trial sponsored by Massachusetts General Hospital investigating NeuroPathways Intervention for glioma/brain tumors is currently r…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
This clinical trial update describes an observational study by the EORTC to assess treatment patterns and outcomes for patients with primary…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. [Phase 1]
Phase 1 trial update on an adenovirus-mediated suicide gene therapy combined with radiotherapy for progressive astrocytoma; the study is cur…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Evaluation of the Variation Over Time of Visuospatial Deficit in Patients With Parietal Lobe Glioma
This clinical trial is evaluating the variation over time of visuospatial deficits in patients with parietal lobe glioma and is currently re…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS [NA]
A clinical trial update notes ongoing research evaluating postoperative navigated repetitive transcranial magnetic stimulation (nrTMS) to ac…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study of GC101 TIL in Brain Glioma (Soochow2) [EARLY_Phase 1]
A Phase 1 study evaluating GC101 TIL for glioma is currently recruiting, sponsored by Shanghai Juncell Therapeutics.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. [EARLY_Phase 1]
Biogenea Pharmaceuticals is conducting an early-phase Phase 1 clinical study to evaluate the safety and potential efficacy of the Tamavaq AI…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: 18F-Fluciclovine PET-MRI in High-grade Glioma [EARLY_Phase 1]
An early-phase trial evaluating 18F-Fluciclovine PET-MRI for imaging high-grade glioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG [EARLY_Phase 1]
This is an early-phase (Phase 1) clinical trial evaluating 18F-Fluciclovine PET-MRI imaging in low-grade glioma, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction
A prospective real-world study is evaluating AI-powered pathology for predicting molecular features of glioma; the trial is currently recrui…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Using the Epitranscriptome to Diagnose and Treat Gliomas [NA]
A clinical trial exploring epitranscriptome-based approaches to diagnose and treat gliomas is described; the study is currently not yet recr…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion [NA]
This clinical trial update describes a study using magnetic resonance elastography to investigate glioma tumor stiffness and adhesion. The t…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide [Phase 1, Phase 2]
Phase 1/2 trial evaluating rhIL-7-hyFc to increase lymphocyte counts in newly diagnosed glioma patients after radiation and temozolomide; re…